{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:28:00Z","timestamp":1754159280846,"version":"3.41.2"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The aim of this study is to summarize and evaluate the quality of evidence regarding the effectiveness and safety of different interventions for patients with cardiomyopathy, based on published meta-analyses through an umbrella review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>The literature was searched via PubMed, Embase, Web of Science, and the Cochrane Library. Two reviewers evaluated the methodological quality of the included articles using the AMSTAR score. In addition, according to the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE), evidence of each outcome was evaluated and graded as \u201chigh,\u201d \u201cmoderate,\u201d \u201clow,\u201d or \u201cvery low\u201d quality for drawing conclusions. Additionally, each outcome was classified into four categories (classes I\u2013IV and nonsignificant).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>High-quality evidence suggested that for patients with cardiomyopathy, stem cell treatment could significantly improve left ventricular ejection fraction (LVEF), left ventricular ejection volume, 6-min walk distance (6-MWD), and New York Heart Association (NYHA) functional classification. High-quality evidence also suggested that for patients with dilated cardiomyopathy (DCM), adding traditional Chinese medicines (TCMs) such as Qili Qiangxin capsule (QQC), Shenmai injection (SMI), Zhigancao, and Shengmai to conventional Western medical treatment could significantly improve clinical effects, including LVEF, 6-MWD, and reductions in inflammatory indicators, left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), and heart rate. In addition, high-quality evidence suggested that for patients with DCM, drugs such as atorvastatin, carvedilol, thyroid hormone, and L-carnitine could significantly improve LVEF and cardiac output and reduce C-reactive protein levels, systolic blood pressure, LVEDD, and left ventricular end-diastolic and end-systolic volumes. Furthermore, implantable cardioverter defibrillator (ICD) therapy could significantly reduce sudden cardiac death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>High-quality evidence showed that cell therapy, atorvastatin, carvedilol, and thyroid hormone have significant improvement effects on the prognosis of cardiomyopathy. In addition, combining traditional Chinese medicines with conventional Western medicine therapy could significantly improve the effectiveness of conventional Western medicine therapy for cardiomyopathy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1544121","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T04:10:19Z","timestamp":1753416619000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["What are the best clinical management strategies for cardiomyopathy? an umbrella review of systematic reviews and meta-analyses"],"prefix":"10.3389","volume":"16","author":[{"given":"Wanru","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.31083\/j.rcm2304141","article-title":"The effect of angiotensin II receptor blockers in patients with hypertrophic cardiomyopathy: an updated systematic review and meta-analysis of randomized controlled trials","volume":"23","author":"Abdelazeem","year":"2022","journal-title":"Rev. Cardiovasc. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jacc.2009.09.047","article-title":"Updated meta-analysis of septal alcohol ablation Versus myectomy for hypertrophic cardiomyopathy","volume":"55","author":"Agarwal","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/eurheartj\/ehp016","article-title":"Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis","volume":"30","author":"Alam","year":"2009","journal-title":"Eur. Heart J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1089\/acm.2012.0361","article-title":"Effectiveness of chinese herbal medicine as an adjunctive treatment for dilated cardiomyopathy in patients with heart failure","volume":"19","author":"Bai","year":"2013","journal-title":"J. Altern. Complementary Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e26475","DOI":"10.1097\/MD.0000000000026475","article-title":"Immunoadsorption treatment for dilated cardiomyopathy A PRISMA-compliant systematic review and meta-analysis","volume":"100","author":"Bian","year":"2021","journal-title":"Medicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"Itc33","DOI":"10.7326\/AITC202303210","article-title":"Cardiac amyloidosis","volume":"176","author":"Bloom","year":"2023","journal-title":"Ann. Intern Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.3390\/jcm9103062","article-title":"Alcohol septal ablation versus septal myectomy treatment of obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"9","author":"Bytyci","year":"2020","journal-title":"J. Clin. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"101256","DOI":"10.1016\/j.ijcha.2023.101256","article-title":"Exercise-based training programs for patients with chronic chagas cardiomyopathy: a systematic review and meta-analysis","volume":"48","author":"Calderon-Ramirez","year":"2023","journal-title":"IJC Heart Vasc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s40256-022-00548-3","article-title":"Effectiveness and safety of thyroid hormone therapy in patients with dilated cardiomyopathy: a systematic review and meta-analysis of RCTs","volume":"22","author":"Chen","year":"2022","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1053\/euhj.1999.1984","article-title":"Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study","volume":"21","author":"Cice","year":"2000","journal-title":"Eur. Heart J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/cells11020240","article-title":"Mesenchymal stem cell therapy in diabetic cardiomyopathy","volume":"11","author":"da Silva","year":"2022","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.hlc.2014.04.007","article-title":"Statin therapy improves long-term survival in non-ischaemic cardiomyopathy: a pooled analysis of 4500 patients","volume":"23","author":"Deo","year":"2014","journal-title":"Heart Lung Circulation"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013433.pub2","article-title":"Stem cell therapy for dilated cardiomyopathy","volume":"7","author":"Diaz-Navarro","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171583","article-title":"Meta-analysis of trimetazidine treatment for cardiomyopathy","volume":"38","author":"Fan","year":"2018","journal-title":"Biosci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/sctm.17-0197","article-title":"CD34(+) cell transplantation improves right ventricular function in patients with nonischemic dilated cardiomyopathy","volume":"7","author":"Frljak","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"E329","DOI":"10.1532\/hsf.2787","article-title":"The impact of atorvastatin on cardiac performance for dilated cardiomyopathy: a meta-analysis of randomized controlled studies","volume":"23","author":"Fu","year":"2020","journal-title":"Heart Surg. Forum"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1161\/01.cir.94.11.2817","article-title":"Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart","volume":"94","author":"Gilbert","year":"1996","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/s1388-9842(00)00064-7","article-title":"The effects of L-carnitine treatment on left ventricular function and erythrocyte superoxide dismutase activity in patients with ischemic cardiomyopathy","volume":"2","author":"G\u00fcrlek","year":"2000","journal-title":"Eur. J. Heart Fail"},{"key":"B20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1093\/eurheartj\/ehv390","article-title":"Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial","volume":"36","author":"Hamshere","year":"2015","journal-title":"Eur. Heart J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1016\/j.jacc.2021.09.1381","article-title":"Effect of mavacamten on echocardiographic features in symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Hegde","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","article-title":"Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches","volume":"402","author":"Heymans","year":"2023","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e071609","DOI":"10.1136\/bmj-2022-071609","article-title":"Dietary sugar consumption and health: umbrella review","volume":"381","author":"Huang","year":"2023","journal-title":"Bmj"},{"key":"B25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1503\/cmaj.081086","article-title":"Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses","volume":"181","author":"Ioannidis","year":"2009","journal-title":"Cmaj"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/circ.146.suppl_1.11351","article-title":"Abstract 11351: surgical myectomy versus alcohol septal ablation among patients with HOCM: a systematic review and meta-analysis","volume":"146","author":"Jaiswal","year":"2022","journal-title":"Conf. Am. Heart Association's"},{"key":"B27","doi-asserted-by":"publisher","first-page":"116457","DOI":"10.1016\/j.biopha.2024.116457","article-title":"Emerging regulatory mechanisms in cardiovascular disease: ferroptosis","volume":"174","author":"Jin","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/eurheartj\/ehm048","article-title":"Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol","volume":"28","author":"Kasama","year":"2007","journal-title":"Eur. Heart J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American heart association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"101461","DOI":"10.1016\/j.cpcardiol.2022.101461","article-title":"Prolactin inhibition in peripartum cardiomyopathy: systematic review and meta-analysis","volume":"48","author":"Kumar","year":"2023","journal-title":"Curr. Problems Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.7150\/ijms.66448","article-title":"Fabry disease and the effectiveness of enzyme replacement therapy (ERT) in left ventricular hypertrophy (LVH) improvement: a review and meta-analysis","volume":"19","author":"Lee","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/CIRCINTERVENTIONS.109.916676","article-title":"Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy comparative rates of overall mortality and sudden cardiac death after treatment","volume":"3","author":"Leonardi","year":"2010","journal-title":"Circulation-Cardiovascular Interv."},{"key":"B33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cardfail.2014.11.005","article-title":"Intracoronary transplantation of CD34(+) cells is associated with improved myocardial perfusion in patients with nonischemic dilated cardiomyopathy","volume":"21","author":"Lezaic","year":"2015","journal-title":"J. Card. Fail"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e15403","DOI":"10.1097\/MD.0000000000015403","article-title":"Clinical efficacy of carvedilol treatment for dilated cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"98","author":"Li T.","year":"2019","journal-title":"Med. (United States)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"E256","DOI":"10.1532\/hsf.2441","article-title":"The efficacy of mesenchymal stem cells for cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"22","author":"Li","year":"2019","journal-title":"Heart Surg. Forum"},{"key":"B36","doi-asserted-by":"publisher","first-page":"682273","DOI":"10.3389\/fphar.2021.682273","article-title":"Therapeutic effects of traditional Chinese medicine on cardiovascular diseases: the central role of calcium signaling","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jchf.2015.06.011","article-title":"A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy","volume":"3","author":"Liebregts","year":"2015","journal-title":"JACC Heart Fail."},{"key":"B38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1536\/ihj.46.113","article-title":"Immunosuppressive treatment for inflammatory cardiomyopathy - meta-analysis of randomized controlled trials","volume":"46","author":"Liu","year":"2005","journal-title":"Int. Heart J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1002\/ptr.7965","article-title":"Fatty acid metabolism disorders and potential therapeutic traditional Chinese medicines in cardiovascular diseases","volume":"37","author":"Liu","year":"2023","journal-title":"Phytother. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10557-020-07118-2","article-title":"Effects of angiotensin II receptor blockers on ventricular hypertrophy in hypertrophic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"36","author":"Liu","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10741-021-10091-z","article-title":"The therapeutic effects of upgrade to cardiac resynchronization therapy in pacing-induced cardiomyopathy or chronic right ventricular pacing patients: a meta-analysis","volume":"27","author":"Lu","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.cjca.2014.03.026","article-title":"Stem cell therapy for the treatment of nonischemic cardiomyopathy: a systematic review of the literature and meta-analysis of randomized controlled trials","volume":"30","author":"Marquis-Gravel","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"Cd009077","DOI":"10.1002\/14651858.CD009077.pub3","article-title":"Pharmacological interventions for treating heart failure in patients with chagas cardiomyopathy","volume":"7","author":"Mart\u00ed-Carvajal","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41569-020-0428-2","article-title":"Epidemiology of the inherited cardiomyopathies","volume":"18","author":"McKenna","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","article-title":"Cell therapy trials for heart regeneration - lessons learned and future directions","volume":"15","author":"Menasch\u00e9","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/0735-1097(94)90174-0","article-title":"Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy","volume":"24","author":"Metra","year":"1994","journal-title":"J. Am. Coll. Cardiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e10627","DOI":"10.7759\/cureus.10627","article-title":"All-cause mortality outcomes of usage of cardiac contractility modulation in patients with dilated cardiomyopathy ineligible for cardiac Re-Synchronization therapy: an updated meta-analysis of randomized controlled trials","volume":"12","author":"Nadeem","year":"2020","journal-title":"Cureus J. Med. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"eabo7622","DOI":"10.1126\/sciadv.abo7622","article-title":"Mavacamten, a precision medicine for hypertrophic cardiomyopathy: from a motor protein to patients","volume":"9","author":"Nag","year":"2023","journal-title":"Sci. Adv."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1161\/01.cir.0000018605.14470.dd","article-title":"Carvedilol decreases elevated oxidative stress in human failing myocardium","volume":"105","author":"Nakamura","year":"2002","journal-title":"Circulation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10741-021-10082-0","article-title":"The efficacy of bone marrow mononuclear stem cell transplantation in patients with non-ischemic dilated cardiomyopathy-a Meta analysis","volume":"27","author":"Nso","year":"2022","journal-title":"Heart Fail Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1161\/CIR.0000000000000599","article-title":"Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American heart association","volume":"138","author":"Nunes","year":"2018","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1161\/CIR.0000000000000938","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","first-page":"CIR0000000000000937","DOI":"10.1161\/CIR.0000000000000937","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/clc.23113","article-title":"Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: systematic review and meta-analysis","volume":"42","author":"Osman","year":"2019","journal-title":"Clin. Cardiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0140-6736(20)31793-1","article-title":"Mavacamten: treatment aspirations in hypertrophic cardiomyopathy","volume":"396","author":"Papadakis","year":"2020","journal-title":"Lancet"},{"key":"B58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cardfail.2006.10.011","article-title":"Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment","volume":"13","author":"Paraskevaidis","year":"2007","journal-title":"J. Card. Fail"},{"key":"B59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/molecules22010163","article-title":"Combination of morroniside and diosgenin prevents high glucose-induced cardiomyocytes apoptosis","volume":"22","author":"Pi","year":"2017","journal-title":"Molecules"},{"key":"B60","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","article-title":"Cardiac involvement in fabry disease: JACC review topic of the week","volume":"77","author":"Pieroni","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/eurheartj\/ehae148","article-title":"Anderson-fabry disease management: role of the cardiologist","volume":"45","author":"Pieroni","year":"2024","journal-title":"Eur. Heart J."},{"key":"B62","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/icvts\/ivx001","article-title":"Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?","volume":"24","author":"Poon","year":"2017","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s43044-023-00328-7","article-title":"Safety and efficacy of mavacamten for treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomized clinical trials","volume":"75","author":"Rabiee Rad","year":"2023","journal-title":"Egypt. Heart J."},{"key":"B64","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nrcardio.2012.109","article-title":"Diagnosis and management of chagas disease and cardiomyopathy","volume":"9","author":"Ribeiro","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"Jama"},{"key":"B66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamacardio.2023.4147","article-title":"Effect of tafamidis on cardiac function in patients with transthyretin amyloid cardiomyopathy: a post hoc analysis of the ATTR-ACT randomized clinical trial","volume":"9","author":"Shah","year":"2024","journal-title":"JAMA Cardiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med. Res. Methodol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"694","DOI":"10.11909\/j.issn.1671-5411.2020.11.001","article-title":"Ablation strategies for arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis","volume":"17","author":"Shen","year":"2020","journal-title":"J. Geriatric Cardiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/ccd.26293","article-title":"A Meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy","volume":"88","author":"Singh","year":"2016","journal-title":"Catheter. Cardiovasc. Interventions"},{"key":"B70","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12471-022-01718-3","article-title":"Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy: an updated meta-analysis and effect on Dutch clinical practice by the task force of the Dutch society of cardiology","volume":"31","author":"Theuns","year":"2023","journal-title":"Neth Heart J."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1002\/ehf2.12762","article-title":"Prednisone and azathioprine in patients with inflammatory cardiomyopathy: systematic review and meta-analysis","volume":"7","author":"Timmermans","year":"2020","journal-title":"Esc. Heart Fail."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/sctm.21-0094","article-title":"Cell therapy for nonischemic dilated cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Tripathi","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/eurheartj\/ehy503","article-title":"Can we remove scar and fibrosis from adult human myocardium?","volume":"40","author":"Vazir","year":"2019","journal-title":"Eur. Heart J."},{"key":"B75","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","article-title":"Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-Year follow-up","volume":"112","author":"Vrtovec","year":"2013","journal-title":"Circ. Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cardfail.2010.11.007","article-title":"Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy","volume":"17","author":"Vrtovec","year":"2011","journal-title":"J. Card. Fail"},{"key":"B77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13287-019-1238-5","article-title":"Safety and efficacy of bone marrow-derived cells therapy on cardiomyopathy: a meta-analysis","volume":"10","author":"Wang","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"102172","DOI":"10.1016\/j.eclinm.2023.102172","article-title":"Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis","volume":"63","author":"Wang","year":"2023","journal-title":"eClinicalMedicine"},{"key":"B79","doi-asserted-by":"publisher","first-page":"155472","DOI":"10.1016\/j.phymed.2024.155472","article-title":"Traditional Chinese medicine and mitophagy: a novel approach for cardiovascular disease management","volume":"128","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"B80","doi-asserted-by":"publisher","first-page":"154630","DOI":"10.1016\/j.phymed.2022.154630","article-title":"Efficacy and safety evaluation of shenmai injections for dilated cardiomyopathy: a systematic review and meta-analysis of randomised controlled trials","volume":"110","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"B81","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.lfs.2017.12.015","article-title":"l-Carnitine and heart disease","volume":"194","author":"Wang","year":"2018","journal-title":"Life Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"B83","doi-asserted-by":"publisher","first-page":"893602","DOI":"10.3389\/fphar.2022.893602","article-title":"Efficacy and safety of qili qiangxin capsule on dilated cardiomyopathy: a systematic review and meta-analysis of 35 randomized controlled trials","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"9491615","DOI":"10.1155\/2021\/9491615","article-title":"Efficacy of L-Carnitine for dilated cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"2021","author":"Weng","year":"2021","journal-title":"BioMed Res. Int."},{"key":"B85","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jamacardio.2022.5099","article-title":"Effects of mavacamten on measures of cardiopulmonary exercise testing beyond peak oxygen consumption: a secondary analysis of the EXPLORER-HCM randomized trial","volume":"8","author":"Wheeler","year":"2023","journal-title":"JAMA Cardiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1161\/01.res.61.3.396","article-title":"L-carnitine treatment improves cardiac performance and restores high-energy phosphate pools in cardiomyopathic Syrian hamster","volume":"61","author":"Whitmer","year":"1987","journal-title":"Circ. Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jcyt.2020.06.006","article-title":"Effects of stem cells on non-ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Xia","year":"2020","journal-title":"Cytotherapy"},{"key":"B88","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.amjcard.2023.10.059","article-title":"The efficacy of cardiac myosin inhibitors versus placebo in patients with symptomatic hypertrophic cardiomyopathy - a meta-analysis and systematic review","volume":"210","author":"Yassen","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"ezad043","DOI":"10.1093\/ejcts\/ezad043","article-title":"Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis","volume":"63","author":"Yokoyama","year":"2023","journal-title":"Eur. J. cardio Thorac. Surg. official J. Eur. Assoc. Cardio Thorac. Surg."},{"key":"B90","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijcard.2005.10.009","article-title":"Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy - a Meta analysis","volume":"112","author":"Zeng","year":"2006","journal-title":"Int. J. Cardiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"912661","DOI":"10.3389\/fcvm.2022.912661","article-title":"Changing trends of the disease burden of non-rheumatic valvular heart disease in China from 1990 to 2019 and its predictions: findings from global burden of disease study","volume":"9","author":"Zheng","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/s0254-6272(17)30147-4","article-title":"Effect of yiqi yangyin prescription in treatment of dilated cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"37","author":"Zhou","year":"2017","journal-title":"J. Traditional Chin. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1544121\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T04:10:40Z","timestamp":1753416640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1544121\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":92,"alternative-id":["10.3389\/fphar.2025.1544121"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1544121","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"article-number":"1544121"}}